May 18, 2012 06:21 ET
NicOx's Ordinary Shareholder Meeting on June 6, 2012
SOPHIA ANTIPOLIS CEDEX, FRANCE--(Marketwire - May 18, 2012) -
ALERT
NicOx's Ordinary Shareholder Meeting
May 18, 2012. Sophia Antipolis, France. [ www.nicox.com ]
NicOx S.A. (EURONEXT: COX) (
The documents mentioned in articles L.225-115, R. 225-81 and R. 225-83 of the French Code de commerce, including a proxy voting form, are sent to shareholders upon written request. These documents will also be made available to shareholders at the headquarters and on the website of the Company ([ www.nicox.com ]).
NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is building an international late-stage development and commercial Ophthalmology Company based around therapeutics, diagnostics and devices. As of March 2012, NicOx holds an 11.8% stake in the UK-based ophthalmology company Altacor, with an option to acquire the remaining shares, as the first step of a transformation into a late-stage development and commercial ophthalmic Company.
NicOx is also developing an internal portfolio of New Molecular Entities (NMEs) through the application of its proprietary nitric oxide-donating R&D platform. The Company's pipeline includes several nitric oxide-donating NMEs for the potential treatment of ophthalmological, inflammatory and cardio-metabolic diseases, which are in development internally and with partners, who include Bausch + Lomb, Merck (known as MSD outside the United States and Canada) and Ferrer.
NicOx S.A. is headquartered in France and is listed on Euronext Paris (Compartment C: Small Caps).
Risks factors which are likely to have a material effect on NicOx's business are presented in the 4th chapter of the « Document de référence, rapport financier annuel et rapport de gestion 2010 » filed with the French Autorité des Marchés Financiers (AMF) on February 29, 2012 and available on NicOx's website ([ www.nicox.com ]) and on the AMF's website ([ www.amf-france.org ]).
NicOx's Ordinary Shareholder Meeting on June 6, 2012: [ http://hugin.info/143509/R/1613226/513706.pdf ]
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NICOX via Thomson Reuters ONE
[HUG#1613226]